These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1735467

  • 1. Monoamine oxidases of the brains and livers of macaque and cercopithecus monkeys.
    Riachi NJ, Harik SI.
    Exp Neurol; 1992 Feb; 115(2):212-7. PubMed ID: 1735467
    [Abstract] [Full Text] [Related]

  • 2. Monoamine oxidases of the human brain and liver.
    Kalaria RN, Mitchell MJ, Harik SI.
    Brain; 1988 Dec; 111 ( Pt 6)():1441-51. PubMed ID: 3208065
    [Abstract] [Full Text] [Related]

  • 3. Blood-brain barrier monoamine oxidase: enzyme characterization in cerebral microvessels and other tissues from six mammalian species, including human.
    Kalaria RN, Harik SI.
    J Neurochem; 1987 Sep; 49(3):856-64. PubMed ID: 2886556
    [Abstract] [Full Text] [Related]

  • 4. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat.
    Kalaria RN, Harik SI.
    J Neurochem; 1987 Nov; 49(5):1589-94. PubMed ID: 3117975
    [Abstract] [Full Text] [Related]

  • 5. Localization in rat brain of binding sites for parkinsonian toxin MPTP: similarities with [3H]pargyline binding to monoamine oxidase.
    Rainbow TC, Parsons B, Wieczorek CM, Manaker S.
    Brain Res; 1985 Mar 25; 330(2):337-42. PubMed ID: 3872699
    [Abstract] [Full Text] [Related]

  • 6. Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity.
    Kalaria RN, Mitchell MJ, Harik SI.
    Proc Natl Acad Sci U S A; 1987 May 25; 84(10):3521-5. PubMed ID: 3495000
    [Abstract] [Full Text] [Related]

  • 7. Nigrostriatal monoamine oxidase A and B in aging squirrel monkeys and C57BL/6 mice.
    Irwin I, Delanney L, Chan P, Sandy MS, Di Monte DA, Langston JW.
    Neurobiol Aging; 1997 May 25; 18(2):235-41. PubMed ID: 9258902
    [Abstract] [Full Text] [Related]

  • 8. Brain region differences and some characteristics of monoamine oxidase type A and B activities in the vervet monkey.
    Murphy DL, Redmond DE, Garrick N, Baulu J.
    Neurochem Res; 1979 Feb 25; 4(1):53-62. PubMed ID: 109783
    [Abstract] [Full Text] [Related]

  • 9. Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products.
    Youngster SK, McKeown KA, Jin YZ, Ramsay RR, Heikkila RE, Singer TP.
    J Neurochem; 1989 Dec 25; 53(6):1837-42. PubMed ID: 2809594
    [Abstract] [Full Text] [Related]

  • 10. Localization of monoamine oxidases A and B in primate brains relative to neuron-specific and non-neuronal enolases.
    Campbell IC, Marangos PJ, Parma A, Garrick NA, Murphy DL.
    Neurochem Res; 1982 Jun 25; 7(6):657-66. PubMed ID: 7121716
    [Abstract] [Full Text] [Related]

  • 11. Regional action of brofaromine on rat brain MAO-A and MAO-B.
    Gerardy J, Dresse A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct 25; 22(7):1141-55. PubMed ID: 9829294
    [Abstract] [Full Text] [Related]

  • 12. Studies on the monoamine oxidase (MAO)-catalyzed oxidation of phenyl-substituted 1-methyl-4-phenoxy-1,2,3,6-tetrahydropyridine derivatives: factors contributing to MAO-A and MAO-B selectivity.
    Wang YX, Castagnoli N.
    J Med Chem; 1995 May 26; 38(11):1904-10. PubMed ID: 7783122
    [Abstract] [Full Text] [Related]

  • 13. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP.
    Salach JI, Singer TP, Castagnoli N, Trevor A.
    Biochem Biophys Res Commun; 1984 Dec 14; 125(2):831-5. PubMed ID: 6335034
    [Abstract] [Full Text] [Related]

  • 14. Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies.
    Del Zompo M, Piccardi MP, Bernardi F, Bonuccelli U, Corsini GU.
    Brain Res; 1986 Jul 23; 378(2):320-4. PubMed ID: 3089539
    [Abstract] [Full Text] [Related]

  • 15. [3H]harman binding experiments. II: Regional and subcellular distribution of specific [3H]harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat.
    May T, Pawlik M, Rommelspacher H.
    J Neurochem; 1991 Feb 23; 56(2):500-8. PubMed ID: 1988553
    [Abstract] [Full Text] [Related]

  • 16. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA, Medvedev AE.
    Med Sci Monit; 2001 Feb 23; 7(1):17-9. PubMed ID: 11208486
    [Abstract] [Full Text] [Related]

  • 17. Studies on the pargyline-binding site of different types of monoamine oxidase.
    Yu PH.
    Can J Biochem; 1981 Jan 23; 59(1):30-7. PubMed ID: 6784898
    [Abstract] [Full Text] [Related]

  • 18. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier.
    Riachi NJ, Harik SI.
    Life Sci; 1988 Jan 23; 42(23):2359-63. PubMed ID: 3259663
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR, Abell CW, Patel NT, Gessner W, Brossi A.
    FEBS Lett; 1985 Jul 08; 186(2):224-8. PubMed ID: 3874094
    [Abstract] [Full Text] [Related]

  • 20. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW, Wong CJ, Hemrick-Luecke SK.
    Life Sci; 1986 Feb 03; 38(5):409-12. PubMed ID: 3945167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.